In the past month, Applied Pharmaceutical Innovation represented Alberta at the Convention of Pharmaceutical Ingredients (CPHI) 2023 in Barcelona, the world’s largest pharmaceutical exhibition.
API’s VP of Commercialization & Growth, Dr. Truong Ta, and Director of Clinical Affairs, Julianna Weber, participated in this global gathering of over 45,000 pharmaceutical professionals, exploring cutting-edge research, discovering innovative solutions, and engaging with industry leaders.
Appreciation is extended to CPHI for hosting an impressive event that brought together pharmaceutical professionals from around the globe. There is anticipation of nurturing the valuable connections established and applying the insights gained to contribute further momentum to Alberta's endeavors.
Julianna Weber and Dr. Truong Ta at the CPHI 2023 in Barcelona.